Both in Biotechnology
Ocugen vs Lexeo Therapeutics
Over the past year OCGN returned −51.6% and LXEO returned −65.6%; their daily moves had a correlation of 0.23.
OCGN −51.6% LXEO −65.6%Growth of $1, one year, split-adjusted
| Metric | OCGN | LXEO |
|---|---|---|
| Price | $0.7452 | $3.11 |
| Market cap | $252.7M | $255.3M |
| Today | +2.83% | +1.63% |
| 1 month | −28.3% | −8.8% |
| 6 months | −50.0% | −47.8% |
| Year to date | −44.8% | −68.7% |
| 1 year | −52.2% | −68.9% |
| Revenue growth (YoY) | +8.4% | — |
| Gross margin | 100.0% | — |
| Net margin | −1671.8% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $15.9M | $211.1M |
| Dividend yield | — | — |
| Volatility (60d) | 71.1% | 69.1% |
| Short % of float | 33.1% | 22.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).